The PROVENT Study will research a combination of 2 investigational monoclonal antibodies for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2). The study is looking at how well the investigational antibodies work and how safe they are.
Research has shown that certain diseases and medications may impact people differently based on their age, gender, and genetic background, including race and ethnicity. For example, COVID-19 has disproportionally impacted both older people and minority populations. Clinical research studies often require large numbers of volunteers from diverse populations to participate in a single study. Sometimes thousands of volunteers are needed to obtain reliable information. This helps to ensure that medications, vaccines, and therapeutic antibodies are generally safe and work for different people, especially those most impacted by the disease or illness.